| Literature DB >> 16443792 |
Marie Lundholm1, Vinicius Motta, Anna Löfgren-Burström, Nadia Duarte, Marie-Louise Bergman, Sofia Mayans, Dan Holmberg.
Abstract
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), or CD152, is a negative regulator of T-cell activation and has been shown to be associated with autoimmune diseases. Previous work has demonstrated a defect in the expression of this molecule in nonobese diabetic (NOD) mice upon anti-CD3 stimulation in vitro. Using a genetic approach we here demonstrate that a novel locus (Ctex) telomeric on chromosome 1 together with the Idd3 (Il-2) gene confers optimal CTLA-4 expression upon CD3 activation of T-cells. Based on these data, we provide a model for how gene interaction between Idd3 (IL-2), Ctex, and Idd5.1 (Ctla-4) could confer susceptibility to autoimmune diabetes in the NOD mouse. Additionally, we showed that the Ctex and the Idd3 regions do not influence inducible T-cell costimulator (ICOS) protein expression in NOD mice. Instead, as previously shown, higher ICOS levels in NOD mice appear to be controlled by gene(s) in the Idd5.1 region, possibly a polymorphism in the Icos gene itself.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16443792 DOI: 10.2337/diabetes.55.02.06.db05-1240
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461